Recombinant proteins for SARS and SARS-CoV-2 (COVID-19, 2019-nCoV) research:
CLSARS004 | Recombinant SARS Associated Coronavirus Envelope, His Tag |
CLSARS005 | Recombinant SARS Associated Coronavirus Nucleocaspid (1-49 a.a.) |
CLSARS006 | Recombinant SARS Associated Coronavirus Nucleocaspid (340-390 a.a.), His Tag |
CLSARS007 | Recombinant SARS Associated Coronavirus Membrane |
CLSARS008 | Recombinant SARS Associated Coronavirus Spike (1-53, 90-115, 171-205 a.a.) |
CLSARS009 | Recombinant SARS Associated Coronavirus Spike (408-470, 540-573 a.a.) |
CLSARS010 | Recombinant SARS Associated Spike Mosaic |
CLSARS011 | Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 |
CLSARS012 | Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S2 |
CLSARS013 | Recombinant Coronavirus 2019 Nucleocapsid |
CLSARS014 | Recombinant Coronavirus 2019 Spike E-Mosaic |
CLSARS015 | Recombinant Coronavirus 2019 Nucleocapsid-Mosaic |
CLSARS016 | Recombinant Coronavirus 2019 Spike (800-1000 a.a.) |
CLSARS017 | Recombinant Coronavirus 2019 Spike (1000-1200 a.a.) |
CLSARS018 | Recombinant Coronavirus 2019 Spike Receptor Binding Domain (300-600 a.a.) |
CLSARS019 | Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1, Sf9 |
CLSARS020 | Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S2, Sf9 |
CLSARS021 | Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 Receptor Binding Domain (319-541 a.a.) |
CLSARS021 | CLSARS021 Recombinant Coronavirus 2019 Spike Receptor Binding Domain (1-260 a.a.) |
CLSARS023 | Recombinant SARS MERS Spike S1, HEK |
CLSARS024 | Recombinant SARS Coronavirus Nucleocapsid (2-422 a.a.), HEK |
CLSARS025 | Recombinant SARS Associated Coronavirus Spike (1-666 a.a.) |
CLSARS026 | Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 (16-685 a.a.) |
CLSARS027 | Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 (16-685 a.a.) Fc |
CLSARS028 | Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 (16-685 a.a.), Biotin |
CLSARS029 | Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 Receptor Binding Domain (319-541 a.a.), Fc |
CLSARS030 | Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 Receptor Binding Domain (319-541 a.a.), Biotin |
CLSARS031 | Recombinant SARS Associated Coronavirus Spike (14-667 a.a.) |
CLSARS032 | Recombinant SARS Associated Coronavirus Spike Receptor Binding Domain (306-527 a.a.) |
SARS-CoV-2 antibodies
SARS-CoV-2 antibodies are manufactured by AffinityImmuno Inc in Canada, and some new products have been added very recently (gold and HRP conjugates for lateral flow and ELISA respectively).
AB-131-291 | Chicken Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Spike Protein S1+S2 Extracellular Domain Antibody |
AB-131-292 | Chicken Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Spike Protein (S1 Domain) Antibody |
AB-131-293 | Chicken Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Spike Protein (S2 Domain) Antibody |
AB-131-294 | Chicken Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Spike S2 Domain Antibody, affinity purified |
AB-131-294-GOLD | Aff. Pur. Chicken anti-SARS-CoV-2 Spike domain S2 Gold conjugate, 40 nm |
AB-131-294-HRP | Aff. Pur. Chicken anti-SARS-CoV-2 Spike domain S2 HRP conjugate |
Cell line from Cedarlane
Cedarlane is now offering the following cell line, which overexpresses native human angiotensin-converting enzyme 2 (ACE2) extracellular domain:
CLA51C2-71C Human ACE2 Stable Cell line-CHO, Stable Recombinant CHO Cells for FACS Analysis and Cell-Based ACE2 Assays (New), read more